(Q73294580)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11115695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11115695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

1 reference

J P Bryan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11115695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C H Henry

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11115695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A G Hoffman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11115695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J E South-Paul

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11115695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J A Smith

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11115695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D Cruess

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11115695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J M Spieker

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11115695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M de Medina

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11115695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11115695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11115695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11115695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

7-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11115695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

743-750

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11115695%20AND%20SRC:MED&resulttype=core&format=json

The diverse patterns of hepatitis A epidemiology in the United States-implications for vaccination strategies

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

An outbreak of hepatitis A during a military field training exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

1 reference

7 January 2021

Multistate outbreak of hepatitis A associated with frozen strawberries

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

Will hepatitis A become a vaccine-preventable disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

The case for routine childhood vaccination against hepatitis A

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

Vaccines to prevent viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

Protection against hepatitis A by an inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

Inactivated hepatitis A vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

Safety and Immunogenicity of a Live Attenuated Hepatitis A Virus Vaccine in Seronegative Volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

1 reference

7 January 2021

Clinical experience with an inactivated hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

Sensitive assays for hepatitis A antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

Safety, tolerability, and immunogenicity of an inactivated hepatitis A vaccine: effects of single and booster injections, and comparison to administration of immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

Detection of total antibody against hepatitis A virus by an automated microparticle enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

Analysis of immunoassays to detect antibodies to hepatitis A virus (anti-HAV) and anti-HAV immunoglobulin M.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

Time course of hepatitis A antibody production after active, passive and active/passive immunisation: the results are highly dependent on the antibody test system used

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

Simultaneous passive and active immunization against hepatitis A

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

Comparative immunogenicity and tolerance of Vaqta and Havrix

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

Acute hepatitis A in a traveler who had received preexposure inactivated hepatitis A virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

Use of hepatitis A vaccine in a community-wide outbreak of hepatitis A.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900301-7

7 January 2021

10.1016/S0264-410X(00)00301-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11115695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference